CGT process development and commercial readiness (Europe)

During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza Netherlands, leaders and innovators from the industry look the stage for a panel discussion around process development and commercial readiness for cell & gene therapy manufacturing.

Speakers:

Anthony Davies, Chair, CEO, Dark Horse Consulting

Felix Hermann, Vice President of CMC, Cimeio Therapeutics

Chaminda Salgado, Vice President of CMC, T-Cypher Bio

Erik Rutjens, Chief Technical Officer, CanCell Therapeutics

Behnam Ahmadian Baghbaderani, Global Head of CGT Process Development

You may also be interested in:

First Name Last Name Business Email Company Name Country

State

Join our community to receive tailored insights and resources. You can unsubscribe at any time.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Used as thumbnail for Powder to Particles podcast.

Small Molecule API & HPAPI Development Capacity

This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma...

Webinar (on-demand)

Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug...

The rapid development of enabled forms and formulations is crucial for tackling the challenges posed...

Presentation (on-demand)

Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery

Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s...

Transforming drug delivery through advanced capsule innovation

Capsules represent one of the oldest pharmaceutical dosage forms, with a history dating back to...

Spray Drying - Bend

Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development

This executive summary explores a risk-based approach to process qualification, demonstrating how...

Webinar (on-demand)

Excipients for Respiratory Delivery of Biologics

Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has...

Christine Lebeault

Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza

In this article Christine Lebeault, Head of Applied Sustainability, Lonza Capsules & Health...

capsules in hand

Capsugel® in-stock vegan capsule program – EMEA

Select from a variety of vegan options to satisfy your market needs quickly. Experience the many...

Couple running with dog

Webinar (on-demand)

Unlocking Pet Joint Health with Collagen - Webinar

Walking, running, playing, jumping. In this webinar, learn how you can support active owners’...

Spray Drying Bend

From Technology Selection to Final Drug Product

Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in...

dry powder inhalation image

Dry Powder Vaccines to Improve Global Access and Pandemic Response

Many vaccines require cold chain storage and distribution, limiting their accessibility in...

front of Tampa building with flags

Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule...

Microdosing, a technique involving the administration of precise, minimal drug doses, can...